ArticleJournal of advanced research2022

Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and

Vijayakumar Jawalagatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.